Trendlines' In-House Innovation Centre Expands to Singapore
Building upon the success of Trendlines Labs in Israel, Trendlines Labs Singapore is an in-house innovation centre focused on inventing medical technologies and developing solutions and products to meet critical unmet needs through close partnerships with healthcare institutions, universities, corporates and the start-up ecosystem in Singapore.
- Building upon the success of Trendlines Labs in Israel, Trendlines Labs Singapore is an in-house innovation centre focused on inventing medical technologies and developing solutions and products to meet critical unmet needs through close partnerships with healthcare institutions, universities, corporates and the start-up ecosystem in Singapore.
- Operating as a business unit of Trendlines Medical Singapore,Labs Singapore will capitalise on Trendlines' strong relationships with decision makers and clinical experts in the medical industry to invent and develop innovative devices, supplies, equipment, and digital concepts.
- Commenting on the establishment of Trendlines Labs Singapore, Todd Dollinger, Chairman and CEO of The Trendlines Group, said, "As a result of our public listing in 2015 and the establishment of Trendlines Medical Singapore in 2016, Trendlines has made remarkable progress in building its presence in the medical technology space in Singapore.
- Trendlines' shares are traded on the Singapore Stock Exchange (SGX: 42T) and in the United States as an American Depositary Receipt (ADR) on the OTCQX (OTCQX: TRNLY).